00:00I am here in IIT Kanpur.
00:03IIT Kanpur is here in the bio-science and bio-engineering
00:06which is Professor Bhushra Ativ.
00:11I am here in the 2000s
00:15in the 2000s,
00:24I have a great day in the 2000s
00:27in the 2000s
00:28I have been doing research and told that prostate cancer is very important.
00:34The prostate cancer is a colorectal cancer, so I have worked on the doctor's doctor's doctor's doctor's doctor.
00:40Here we go to the doctor's doctor's doctor.
00:41I have been doing this with the doctor's doctor's doctor's doctor's doctor.
00:59I am very excited to see that my childhood was very excited to be in the beginning.
01:08I was very excited to see that the clon of the wizard had a little bit of a cladoscope.
01:17They used to play with magnets and they used to create something.
01:23After that, when I started growing up, I had a lot of friends from Bali and lecturers.
01:30They used to go to their lab.
01:32They used to study statements.
01:36They used to study statements.
01:38They used to study 3-4 classes.
01:42I was watching many many, too.
01:42And I looked at the risks in my experience...
01:44But I was wondering if I was thinking...
01:46And I was wondering, what has the impact of life sciences?
01:50And then I came to get my interest in terms of kinds.
01:54And then I went to take my experience and I went viral...
01:57And I got to take my experience.
01:57That's why I was thinking about cancer.
01:59So cancer is a very serious state.
02:00What can we do with cancer?
02:04And then, what do you need to do with cancer?
02:06What do you need to do with cancer?
02:08Cancer...
02:09So, the cancer disease is a lot of challenging because it is a lot of heterogeneous.
02:18Every cell has a different type of gene signature which makes it very subtle.
02:43So, the cancer disease is a different type of gene, which is a different type of gene, which is a
02:47different type of gene.
02:56So, the disease is a different type of gene, which is a different type of gene.
03:04So, the disease is a different type of gene.
03:04So, my PhD has cancer.
03:10I don't know exactly what it is.
03:15My PhD was genetic proxy.
03:18When you see a genetic gene, it is a genetic gene.
03:23You can see it in the lower of the cell.
03:27So, my PhD has a genetic gene.
03:31But, when you see it, it is a genetic gene.
03:37It is a little bit of genetic gene.
03:40So, if you look at DNA, the problem is that DNA and chromosome is very similar to cancer.
03:49In cancer, it can be a gene sequence, and the chromosome is very similar to that.
03:56So, my interest has developed and realized that I have to work in this way and help mankind.
04:04So, I was thinking that I was in New Delhi, in the department of biology industry, Dr. Vita Singh was
04:16retired, and I worked with him.
04:19And then I worked with cancer research.
04:23। बहुति , एक वर भारत वर कानी है को देखती है।
04:30तो उसको किस चैन्स ना है को आदो है।
04:36भारत वह जो जीवन इस देखते हैं , लगता है और अब यह बढ़ी जा है।
04:43and every year you will see the number of cases that you will see the number of cases.
04:51One thing that you will see in other countries is oral cancer.
04:57It is a cancer cancer because there is a lot of cancer.
05:01In other countries you will see that it will not be able to see that.
05:04In this year you will see IIT's work.
05:06So, IIT's work.
05:12How do you see it?
05:17I have never felt like this.
05:21There are some challenges in this world.
05:26First of all, I have seen a scientist.
05:29I have seen a scientist in the university course.
05:33I have seen a scientist in the university course.
05:35But I have seen a scientist in the university course.
05:36Yes, there is a manila.
05:37But it is a very supportive environment.
05:40Especially when the manila is young,
05:42the professor is a graduate of university.
05:45It is a supportive environment.
05:50It is not a supportive environment.
05:51It is not a person that you have not done.
05:54How are the participants in this world living ?
05:54Yes, it is not awan mummy.
05:59Probably they are a 244.
06:04What does the presentation of SARS mostra occur?
06:09Yes, after the time of SARSucha,
06:11each exposure can be noticed.
06:16Hydros monartz.
06:18Also, necesitажи with regard to SARSció site,
06:21we have inspired cancer,
06:22we have轉くため
06:22in India.
06:23In India, there are genomic sequencing, which is personalized predation.
06:31Cancer is a bit more heterogeneous.
06:36In one person, you can see one patient with one patient.
06:42So genetic sequencing is very important.
06:44Because you can see which patient has a cancer.
06:51There is a problem with a cancer.
06:51In a case, there are many trasers with molecules,
06:56which means the people have no issues.
06:59But health individuals have sequencing.
07:03Not all of those have sequencing,
07:06but people can tell them that they can tell them
07:08whether they are the legion types and they have a ligon type.
07:21It just seems like the disease is coined.
07:21So we can see what has happened in India.
07:25In India we have done a lot of work on genomics field.
07:29You can do a very confusing consideration by making a complex tool for this.
07:35The brain cancer is a big project, which has been happening on India.
07:41Tertilegative brain cancer and the remaining brain cancer is about a sequence.
07:46It's been a long time since I joined myself.
07:52We have had cancer in Kolkata, in our lab, and in our small lab, we have had a prostitute.
07:59I think that we can integrate all of this data to help us,
08:06So, we are going to talk about our genes, which are altered, which are pathways, which are effective biomarkers, which
08:14can detect more quickly.
08:15The other thing is that people are coming in the field of immunotherapy.
08:19In the IT Bombay, we have discovered a cardiovascular therapy, which is not cause-effective.
08:30...
08:30...
08:31...
08:32...
08:32...
08:34in a minute this year we have increased because the most important thing is effortability
08:38and based on AI, artificial intelligence, state learning
08:50we apply it to apply it so that we die dose
08:54like digital pathology
08:57So, in many cancers, the pathologists know that there is cancer or not in any stage.
09:05If there is stage 2, 3 or 4.
09:08So, the pathologists know that every pathologist is different.
09:14One pathologist says that stage 3, the other one says that stage 4.
09:18So, if you have AI, machine learning, take learning,
09:25So, you can find this stage 3.
09:34And first of all, you can find the stage 3.
09:36And how many more?
09:37So, you know, the answer is that to the target 1,
09:40and these symptoms of the pathologists know that בח cigarette is going to be affected.
09:47So, you can see that the волus' symptoms that we are using.
09:51The question is, what is the question of the country?
09:58The question is, what is the question of the country?
10:10When you are working in a special 1939, you've pushed a new dream with 1 hour ,
10:16you've pushed a long drive and made новые activities and things like that.
10:19Because challenges areThere, they are current challenges.
10:24I think it's very important all the challenges that you have already worked,
10:30so I feel for those who need to earn –
10:31I think that all the learning changes are open to your clockwiserizялty.
10:36My personal experience is that whatever you are going on in the life, you will be able to do anything.
10:43So, you will be able to keep your mind on your mind.
10:47And if you don't mind, you will be able to keep your mind on your mind.
10:50If you want to keep your mind on your mind, you will be able to keep your mind on your
10:57mind.
11:00I will be able to keep your mind on your mind.
11:06I will be able to keep your mind on your mind and on your mind.
11:21I will be able to keep your mind on your mind.
Comments